Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Dr. Aniruddha Ganguly is responsible for providing guidance to the planning, development, implementation, and evaluation of assigned biomedical research programs. These include molecular diagnostic technologies, extracellular RNA/exosome/extracellular vesicles in cancer diagnosis, brain tumor research, and clinical trials evaluation for the Biomarker, Imaging, and Quality of Life Studies Funding Program, as well as core correlative science studies. He organizes and hosts Cancer Diagnosis Program Science Sessions. He has developed Program Project (P01) Development Guidance to support P01 investigators, particularly new investigators in their pre-application development stage. 

Before joining the NCI in 2011 as a Program Director, he served as an Assistant Professor at Harvard Medical School/Harvard University for many years, directing and conducting cancer biology research and teaching MD/DMD students. During that time, he discovered a new protein-protein interaction between CEA and a 115 kDa monocyte/macrophage protein that has implications in colon tumorigenesis. He supervised a CLIA certified Laboratory of the department of Pathology at Massachusetts General Hospital. His research was funded by NIH R01, Corporate and Foundation grants. He was scientific advisor of biotechnology companies.

He has expertise in mechanisms of tumor development and metastasis, tumor microenvironment, tumor cell-macrophage interactions, biospecimen processing and banking, cancer biomarkers, clinical assay development, molecular analysis technologies/informatics technology for cancer research, and cancer health disparities research. 

He received many awards including, Bharat Gaurav (Pride of India) (2010) from India, excellence in teaching awards (2007 & 2011) from Harvard Medical School, Partners in Excellence Award from Mass General Hospital/Partners HealthCare (2009), NCI Director’s Awards of Merit (2014 & 2015), and NIH Director’s Award (2024).

Selected Publications

  • Updated:
Email